Home / Insights
Insights
Insights
Education first — including the parts of this field that are unsettled.
These articles discuss general science and published research. They are not descriptions of our services, and they make no claims of results. Where the evidence is contested or thin, they say so.
Regenerative science & regulation
- What are connective tissue allografts?
Donor-derived tissue products, their intended function, and the regulatory category they occupy. - What is Wharton's jelly?
A specific connective tissue with a specific structural role, named for an English physician in 1656. - HCT/Ps and Section 361
The regulatory category most tissue products fall into, and what it does and does not require. - 21 CFR Part 1271, in plain language
The regulation itself, what it requires of establishments, and what it does not address. - FDA-registered is not FDA-approved
Two phrases that sound similar, mean entirely different things, and are frequently conflated in marketing. - Homologous use, explained
The requirement that a tissue perform the same basic function in the recipient that it performed in the donor. - Section 361 and Section 351
Which pathway a product falls under is determined by what it is and how it is used — not by what a manufacturer prefers. - How donor tissue is screened and processed
The safety framework that Section 361 regulation is actually built around. - What 'cushioning and structural support' means
Precise language, chosen for a reason, and what it rules out. - How to read a clinical study
Claims in this field are usually backed by a citation. Reading the citation is where the real information is. - Sample size and control groups
Two concepts that explain most of the gap between what small studies find and what larger ones later confirm. - Registry, trial, or case series?
Three things frequently described as 'studies' that support very different conclusions. - Red flags in regenerative medicine marketing
Patterns that have drawn regulatory attention, and what they indicate. - Questions to ask any regenerative medicine clinic
Every one of these is answerable. Difficulty answering is itself information.
Patient navigation
- What is a good-faith exam?
The evaluation that establishes whether a treatment is appropriate before it is provided. - Informed consent in elective medicine
A process, not a signature — and one that carries extra weight when the procedure is optional and self-funded. - What is concierge medicine?
A model built on smaller patient panels and direct access, with trade-offs worth understanding. - Concierge vs traditional primary care
Two models with real differences and real trade-offs in both directions. - Preparing for a first consultation
Preparation is the difference between a useful first appointment and one spent reconstructing basic history. - How to evaluate health claims online
A method that works across topics, and does not require a medical background. - Understanding treatment financing
Financing is a credit product. It should be evaluated as one. - The FTC Cooling-Off Rule
A federal cancellation right that applies to certain sales made away from a seller's permanent place of business. - Questions worth asking any wellness clinic
Applicable well beyond regenerative medicine — to IV therapy, hormone programmes, weight management and aesthetics alike. - 'Individual results vary' is not boilerplate
The phrase appears so often it has become invisible. It is describing something real.
Movera Wellness Institute. Medical services are provided by licensed California practitioners. Supervising physician: Dr. Arnold S. Kremer, DO (CA license #20A4242).
Educational content. This page provides general information in line with the disclosures below; it is not medical advice or a claim of results. Eligibility for any service is determined by a licensed provider through a good-faith exam.